Showing entries 1 to 3 of 12
The concept of "personalised medicine" has been knocking around the pharmas and regulators for years now without making much progress. To move forward we must disambiguate the term "personalised".
I think pain is interesting id DMD - because I think there is a fundemental relationship between pain and dystrophin.
Lobbying for Exon skipping as a platform drug.